- Potential benefitIncreases patient access by allowing more clinicians to document shoe coverage eligibility.
- Potential benefitReduces beneficiary wait times and administrative delays for obtaining covered diabetic shoes.
- Potential benefitEnables more efficient use of primary care workforce for diabetes foot care.
Promoting Access to Diabetic Shoes Act
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S2973-2974)
This bill amends section 1861(s)(12) of the Social Security Act to allow nurse practitioners and physician assistants, in addition to physicians, to satisfy Medicare documentation requirements for coverage of certain therapeutic shoes and inserts for individuals with diabetes.
Access benefits emphasized by left and center; right focuses on program integrity
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment intended to expand who may satisfy Medicare documentation requirements for diabetic shoes.
This bill amends section 1861(s)(12) of the Social Security Act to allow nurse practitioners and physician assistants, in addition to physicians, to satisfy Medicare documentation requirements for coverage of certain therapeutic shoes and inserts for individuals with diabetes.
Low controversy, narrow scope, and modest fiscal effect increase chances; success depends on legislative timing and packaging.
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment intended to expand who may satisfy Medicare documentation requirements for diabetic shoes. The purpose is clear and the target provision is identified, but the draft contains syntactic/textual problems and omits fiscal, definitional, and oversight detail.
Access benefits emphasized by left and center; right focuses on program integrity
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenCould raise Medicare spending if utilization of covered shoes increases.
- Potential burdenMay increase inconsistent documentation quality and inappropriate coverage claims.
- Potential burdenCould heighten fraud or abuse risk absent adjusted oversight and audit processes.
Why the argument around this bill splits.
Access benefits emphasized by left and center; right focuses on program integrity
Likely supportive because it expands access to medically necessary diabetic footwear by enabling non‑physician clinicians to certify coverage.
Seen as removing an unnecessary administrative barrier for patients, especially in underserved areas.
Generally favorable as a targeted, low‑cost reform that increases access and reduces administrative friction.
Would want modest safeguards and a cost estimate from CMS before broad implementation.
Cautiously open to the change because it reduces an access barrier and leverages non‑physician providers.
However, some conservatives will worry about federal changes to scope‑of‑practice and potential program integrity risks.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Low controversy, narrow scope, and modest fiscal effect increase chances; success depends on legislative timing and packaging.
- No congressional cost estimate provided
- Potential small increase in Medicare expenditures unknown
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Access benefits emphasized by left and center; right focuses on program integrity
Low controversy, narrow scope, and modest fiscal effect increase chances; success depends on legislative timing and packaging.
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment intended to expand who may satisfy Medicare documentation requirements for diabetic shoes. The purpose is clear and the targ…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.